Zixi Wang

机构：First Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0001-8092-7073

发表论文 7 篇 · 总被引 447 次 · h-index 7

代表论文

• Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions (2020 · Frontiers in Immunology · 被引 160)
• IL-10 Enhances Human Natural Killer Cell Effector Functions via Metabolic Reprogramming Regulated by mTORC1 Signaling (2021 · Frontiers in Immunology · 被引 75)
• Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy (2023 · Molecular Cell · 被引 65)
• In Situ Activated NK Cell as Bio‐Orthogonal Targeted Live‐Cell Nanocarrier Augmented Solid Tumor Immunotherapy (2022 · Advanced Functional Materials · 被引 64)
• Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1 (2025 · Cell Metabolism · 被引 50)
• The mTOR signalling in corneal diseases: A recent update (2023 · Biochemical Pharmacology · 被引 20)